Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Snyder, S. H. Articles by Ferris, C. D. Search for Related Content PubMed Citation Articles by Snyder, S. H. Articles by Ferris, C. D. Neurotransmitters Molecular Biology

Novel Neurotransmitters and Their Neuropsychiatric Relevance

OBJECTIVE: The purpose of this review is to integrate insights regarding novel neurotransmitters or neuromodulators of neuropsychiatric significance. METHOD: Evolving concepts of neurotransmitter criteria are reviewed in light of the unexpected properties displayed by recently identified transmitters. RESULTS: Classic criteria for transmitters were based on the properties of acetylcholine but were markedly revised with the recognition of the catecholamines, serotonin, -aminobutyric acid (GABA), and other amino acid transmitters and neuropeptides. Nitric oxide and carbon monoxide are notably atypical, as they are not stored in synaptic vesicles, are not released by exocytosis, and do not act at postsynaptic membrane receptor proteins. D-Serine, recently appreciated as the endogenous ligand for the glycine site of the glutamate N-methyl-D-aspartate (NMDA) receptor, overturns fundamental axioms of biology as well as those of neuroscience. It is a D-amino acid, and it is synthesized and stored in glia rather than neurons. Released glutamate acts on receptors on the protoplasmic astrocytes closely apposed to the synapse to release D-serine, which coactivates postsynaptic NMDA receptors together with glutamate. D-Serine is formed by serine racemase, which directly converts L-serine to D-serine. Inhibitors of this enzyme should reduce NMDA neurotransmission and might be therapeutic in stroke and other conditions associated with glutamate excitotoxicity. CONCLUSIONS: The diversity of novel neurotransmitters and venues of their activity afford multiple opportunities for therapeutic intervention.

This article has been cited by other articles:

				M. Taziaux, M. Keller, J. Bakker, and J. Balthazart Sexual Behavior Activity Tracks Rapid Changes in Brain Estrogen Concentrations J. Neurosci., June 13, 2007; 27(24): 6563 - 6572. [Abstract] [Full Text] [PDF]

				C. W. Leffler, H. Parfenova, A. L. Fedinec, S. Basuroy, and D. Tcheranova Contributions of astrocytes and CO to pial arteriolar dilation to glutamate in newborn pigs Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2897 - H2904. [Abstract] [Full Text] [PDF]

				H. Wolosker D-Serine Regulation of NMDA Receptor Activity Sci. Signal., October 10, 2006; 2006(356): pe41 - pe41. [Abstract] [Full Text] [PDF]

				E. Kartvelishvily, M. Shleper, L. Balan, E. Dumin, and H. Wolosker Neuron-derived D-Serine Release Provides a Novel Means to Activate N-Methyl-D-aspartate Receptors J. Biol. Chem., May 19, 2006; 281(20): 14151 - 14162. [Abstract] [Full Text] [PDF]

				J. Balthazart, M. Baillien, and G. F. Ball Rapid Control of Brain Aromatase Activity by Glutamatergic Inputs Endocrinology, January 1, 2006; 147(1): 359 - 366. [Abstract] [Full Text] [PDF]

				H. Katsuki, M. Nonaka, H. Shirakawa, T. Kume, and A. Akaike Endogenous D-Serine Is Involved in Induction of Neuronal Death by N-Methyl-D-aspartate and Simulated Ischemia in Rat Cerebrocortical Slices J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 836 - 844. [Abstract] [Full Text] [PDF]

				L. A. Slomowitz, F. B. Gabbai, S. J. Khang, J. Satriano, S. Thareau, A. Deng, S. C. Thomson, R. C. Blantz, and K. A. Munger Protein intake regulates the vasodilatory function of the kidney and NMDA receptor expression Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2004; 287(5): R1184 - R1189. [Abstract] [Full Text] [PDF]

				S. J. Gibbons and G. Farrugia The role of carbon monoxide in the gastrointestinal tract J. Physiol., April 15, 2004; 556(2): 325 - 336. [Abstract] [Full Text] [PDF]

				K. Hashimoto, T. Fukushima, E. Shimizu, N. Komatsu, H. Watanabe, N. Shinoda, M. Nakazato, C. Kumakiri, S.-i. Okada, H. Hasegawa, et al. Decreased Serum Levels of D-Serine in Patients With Schizophrenia: Evidence in Support of the N-Methyl-D-Aspartate Receptor Hypofunction Hypothesis of Schizophrenia Arch Gen Psychiatry, June 1, 2003; 60(6): 572 - 576. [Abstract] [Full Text] [PDF]

				L. Chen, M. Muhlhauser, and C. R. Yang Glycine Tranporter-1 Blockade Potentiates NMDA-Mediated Responses in Rat Prefrontal Cortical Neurons In Vitro and In Vivo J Neurophysiol, February 1, 2003; 89(2): 691 - 703. [Abstract] [Full Text] [PDF]

				S. Pind, E. Slominski, J. Mauthe, K. Pearlman, K. J. Swoboda, J. A. Wilkins, P. Sauder, and M. R. Natowicz V490M, a Common Mutation in 3-Phosphoglycerate Dehydrogenase Deficiency, Causes Enzyme Deficiency by Decreasing the Yield of Mature Enzyme J. Biol. Chem., February 22, 2002; 277(9): 7136 - 7143. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2000 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us